This highlights the role of the tissue microenvironment and its influence on metabolic alterations in various cancers and cancer progression. In situ HK2, LDHA, PKM2, PDKs, PDHs, factor inhibiting hypoxia (FIH), and different PHDs were studied in tissues over the last few decades. This evidence concerns the gene HK2 and cancer.